I-5-Fluorocytosine (5-FC) CAS 2022-85-7 Purity ≥99.5% (HPLC) I-Capecitabine Emtricitabine Intermediate Factory
I-Commercial Supply Ehlobene Ne-Capecitabine:
I-5-Fluorocytosine CAS: 2022-85-7
2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine CAS: 161599-46-8
1,2,3-Tri-O-acetyl-5-deoxy-β-D-ribofuranose CAS: 62211-93-2
I-Capecitabine CAS: 154361-50-9
Igama | 5-Fluorocytosine |
Omqondofana | 5-FC;I-Flucytosine;4-Amino-5-fluoro-2-hydroxypyrimidine |
Inombolo ye-CAS | 2022-85-7 |
Inombolo yeCAT | I-RF-PI175 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C4H4FN3O |
Isisindo samangqamuzana | 129.09 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | I-Crystalline Powder Emhlophe noma Cishe Emhlophe |
Ukuhlonza IR | I-spectrum yokumuncwa kwe-infrared yesampula kufanele ihambisane ne-spectrum evamile |
Ukuhlanzeka / Indlela Yokuhlaziya | ≥99.5% (HPLC) |
I-Cytosine | ≤0.10% |
Noma Ikuphi Okunye Ukungcola Komuntu Ngamunye | ≤0.10% |
Ukuncibilika | Incibilika Kancane Emanzini;Incibilika Kancane Otshwaleni;I-Paractically ku-Chloroform naku-Ether |
Ukulahlekelwa Ekumisweni | ≤1.5% w/w (ku-105℃ 4 h) |
Izinsalela ekushiseni | ≤0.10% w/w |
Izinsimbi Ezisindayo (Pb) | ≤20ppm |
I-fluoric | ≤500ppm |
I-5-Fluorouracil | ≤0.10% |
Isivivinyo | 98.5%~101.0% (kubalwe ngokomisiwe) |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Capecitabine & Emtricitabine Intermediate;Pharmaceutical Intermediates |
Umkhiqizo okhuphukayo | I-Cytosine CAS: 71-30-7 |
I-5-Fluorocytosine (5-FC) CAS: 2022-85-7 Indlela Yokuhlaziya
Ukubukeka-Okumhlophe noma Okucishe Kube I-Crystalline Powder Emhlophe
Ukulahlekelwa Ekusuleni-Yomise ku-105 amahora angu-4: ayilahlekelwa ngaphezu kuka-1.50% wesisindo sayo.
Insalela Ekushiseni-hhayi ngaphezu kuka-0.1%.
I-Heavy Metals - hhayi ngaphezu kuka-0.002%.
I-Fluoride-Hlanganisa u-70 mL wesixazululo esisanda kulungiswa se-potassium chloride esigcwele esino-30 ml we-isopropyl alcohol, gcwalisa i-electrode nge-supernatant ecacile, bese uvumela i-electrode ukuthi ihlale kule ngxube amahora angekho ngaphansi kwama-2 ngaphambi kokusetshenziswa, noma okungcono kakhulu ebusuku.
Lapho uthatha izilinganiso, dlulisela isixazululo kubhekhakhi engu-150-mL, bese ucwilisa ama-electrode.Faka ibha eshukumisayo enama-polytef kubhekha, beka ibhekha kusivusi kazibuthe esinendawo engaphezulu evalekile, bese uvumela ukunyakazisa kuze kufinyelelwe ukulingana (cishe imizuzu engu-1 ukuya kwemi-2).Hlanza futhi womise ama-electrode phakathi kwezilinganiso, uqaphele ukuthi ungaklwebheli ikristalu ku-electrode ye-ion ethile.
Linganisa amandla okulungiselelwa Okujwayelekile ngakunye, bese uhlela ukugxila kwe-fluoride, ngo-mg nge-100 mL ngayinye, ngokuqhathanisa namandla, ku-mV, ephepheni le-semilogarithmic.Linganisa amandla okulungiselela Ukuhlolwa, bese unquma ejikeni elijwayelekile ukugcwala kwe-fluoride, ngo-mg nge-100 ml ngayinye.Bala iphesenti le-fluoride engxenyeni ye-Flucytosine ethathwe ifomula:
C / 10
lapho u-C ewukugxiliswa kwe-fluoride, ku-mg ku-100 mL, kusukela kwijika elijwayelekile: akutholakali ngaphezu kuka-0.05% we-fluoride.
I-Fluorouracil-Dissolve 250 mg ku-10 mL wengxube ye-glacial acetic acid namanzi (4:1).Faka u-20 µL walesi sixazululo epuletini le-chromatographic lisendlalelo oluncane olunamekwe ngesendlalelo esingu-0.5-mm sengxube yejeli ye-chromatographic.Epuletini elifanayo sebenzisa u-20 µL, ekunyusweni okungu-10-µL, ka-0.025 mg ngesixazululo se-mL se-USP Fluorouracil RS kungxube ye-glacial acetic acid namanzi (4:1).Yakha i-chromatogram ngengxube ye-chloroform ne-glacial acetic acid (13:7) kuze kube yilapho i-solvent yangaphambili isuka endaweni engekho ngaphansi kuka-14 cm ukusuka lapho ivela khona.Susa ipuleti ekamelweni elikhulayo, futhi uvumele i-solvent ihwamuke.Thola amachashaza epuletini ngokubheka ngaphansi kwemisebe ye-UV yamaza amafushane: noma iyiphi indawo evela esixazululweni esivivinywayo ayinkulu ngosayizi nokuqina kunendawo eku-RF efanelekile ekhiqizwe isixazululo Esijwayelekile, esihambisana nokungadluli ku-0.1% we i-fluorouracil.
I-Assay-Place cishe u-400 mg we-Flucytosine, ukalwe ngokunembile, ebhekhani elingu-250-mL, engeza u-150 mL wengxube yevolumu engu-2 ye-glacial acetic acid kanye nevolumu engu-1 ye-acetic anhydride, bese uncibilikisa, ufudumale kancane uma kunesidingo.Titrate potentiometrically nge-0.1 N perchloric acid VS, usebenzisa isistimu ye-electrode yengilazi ye-calomel.Yenza isinqumo esingenalutho, futhi wenze noma yikuphi ukulungisa okudingekayo.I-mL ngayinye ka-0.1 N perchloric acid ilingana no-12.91 mg we-C4H4FN3O.I-Flucytosine iqukethe amaphesenti angekho ngaphansi kwamaphesenti angu-98.5 futhi angabi ngaphezu kwamaphesenti angu-101.0 we-C4H4FN3O, abalwe ngokomisiwe.
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo nomphakeli we-5-Fluorocytosine CAS: 2022-85-7 (Fluorocytosine; 5-FC) enekhwalithi ephezulu, esetshenziswa kabanzi ku-organic synthesis, ukuhlanganiswa kwemithi ephakathi kwemithi kanye ne-Active Pharmaceutical Ingredient. (API) synthesis.I-5-Fluorocytosine (i-CAS: 2022-85-7) iphakathi kwe-Capecitabine (CAS: 154361-50-9) kanye ne-Emtricitabine (CAS: 143491-57-0).
I-5-Fluorocytosine iyi-analog e-fluorinated ye-cytosine.I-5-FC igunyazwe i-US Food and Drug Administration (FDA) njenge-ejenti elwa nesikhunta esetshenziselwa ukwelapha i-Candida ne-Cryptococcus.Kamuva nje ngokuthuthukiswa kokwelashwa kofuzo, i-5-FC yethulwe njenge-prodrug ihlanganiswe nofuzo lokuzibulala lwe-cytosine deaminase.